The purpose of the present study was to evaluate the neural protein expression pattern of human multipotent mesenchymal stromal cells (hMSCs) treated with forskolin (free-form/FF). The study investigated forskolin's capacity to enhance intracellular levels of cyclic adenosine monophosphate (cAMP) by activating adenylate cyclase and probably by inducing neuron-like cells in vitro. In addition, because nanotechnology is a growing field of tissue engineering, we also assessed the action of a new system called the nanostructured-forskolin (NF) to examine the improvement of drug delivery. Afterwards, the cells were submitted to low-level laser irradiation to evaluate possible photobiostimulatory effects. Investigations using the immunofluorescence by confocal microscopy and Western blot methods revealed the expression of the neuronal marker β-tubulin III. Fluorescence intensity quantification analysis using INCell Analyzer System for β-tubulin III was used to examine significant differences. The results showed that after low-level laser irradiation exposure, there was a tendency to increase the β-tubulin III expression in all groups, as expected in the photobiostimulation process. Notably, this process induced for irradiation was more pronounced in irradiated nanoforskolin cells (INF) compared to non-irradiated free-forskolin control cells (NFFC). However, there was also an increase in β-tubulin III protein expression in the groups: irradiated nanocontrol cells (INC) compared to non-irradiated free-forskolin control cells (NFF) and after treatment with non-irradiated freeforskolin (NFF) and non-irradiated nanoforskolin (NNFC). We concluded that the methods using low-level laser irradiation and/or nanoparticles showed an up-regulation of neural-protein expression in hMSCs that could be used to facilitate cellular therapy protocols in the near future.
Introduction
Low-intensity laser irradiation is a common approach used for regenerative effects in cells and tissue on many in vitro and in vivo applications, especially to stimulate osteoblastic growth [1, 52, 58] and neurons [11, 17, 50, 54] derived from mice. Concerning the benefits of laser light in medicine, two therapies have been broadly studied: Photodynamic Therapy (PDT) and Low-Level Laser Therapy (LLLT). The results of PDT dates from the 60 s when Lipson and Baldes [26] used haematoporphyrin derivative (HPD) as a photoactive compound. Since then, several studies have established PDT as a clinical protocol for the treatment of several oncological, dermatological, and ophthalmic diseases [2, 39] . The basic protocol can be defined as the administration of a nontoxic drug or dye, known as photosensitizer (PS) in a well-designed drug delivery system [42] , followed by the illumination of the site with visible light, which, in presence of oxygen, generates cytotoxic species and consequently leads to cell death and tissue destruction.
In contrast to the reports of Mester [32] , the PDT studies from Lipson and Baldes one decade later demonstrated that low-dose laser stimulation regenerates burns in rats, which led to numerous studies on LLLT as a photobiomodulation process for various medical applications, including wound repair [27] , dermatological diseases [30] , neurological damage [56] , blood disorders [36] , dentistry [10] , pain and inflammation [61] as well as treatment of chronic skin ulcers [24] . Two mechanisms were suggested to be involved in the light-cell interactions. One is acceleration of electron transfer between redox pairs in some sections of the respiratory chain in the mitochondria [22] . The other is the production of small amounts of reactive oxygen species (ROS) induced by light absorption using cytochrome c oxidase to accelerate ATP production and cellular proliferation [38] . Recently, it has been proposed that photoactivation stimulates proliferation of dermal fibroblasts caused by ROS, which activate extracellular signal-regulated kinases (ERK) [19] . ERK contributes to the regulation of critical cell processes, including proliferation as well as differentiation, survival, and apoptosis. It has been suggested that fibroblast growth factor (FGF) stimulation leads to reactivation of ERK signalling [21] . In vitro studies have reported the use of light for biostimulation of fibroblast proliferation [39] , osteoblast growth for bone remodelling [58] and 3D dermal equivalents [43] , which support the expected outcomes for the proposed work.
The concept of nanotechnology was first described by Richard Feynman (1959, Nobel prize) to characterize the development of molecular machines that would have the capacity to control material properties at the nanoscale, i.e., components smaller than 100 nm in at least one dimension [60] . Since then, new drug delivery systems, such as liposomes, stealth liposomes, polymeric nanoparticles, dendrimers, nanocomposites and many others, have been developed and there has been an exponential increase in the appearance of new molecules or adaption of old molecules for new drug delivery systems (DDS) [3, 7, 31, 35, 37] . For this reason, nanomaterials could enhance delivery and treatment efficiency compared to conventional materials, and rapid progress in nanomedicine is expected [43, 60] . As far as we know, there are no studies correlating in vitro data for low-intensity laser irradiation with nanodrug delivery systems. Thus, the aim of this study was to compare the photobiomodulation effects from visible light laser irradiation of nanostructured-forskolin (NF) to the free-form of the drug (forskolin, FF). For the nanostructured form, forskolin has been reported to induce up-regulation of neural genes and proteins due to its ability to stimulate the levels of cAMP, [46] . To do so, hMSCs derived from bone marrow were used as a source to examine possible enrichment of neuron-like cells in culture. An attribute of MSCs from bone marrow and adipose tissues among others can differentiate mesenchymal tissue in vitro, including osteocytes, chondrocytes and adipocytes [9, 45, 62] .
MSCs are multipotent cells that are present in virtually all post-natal organs and human tissues [14] , and they are located at the perivascular sites of different tissues [13, 14] , which may indicate the existence of a systemic reservoir of multipotent progenitor cells [12] .
In the past, Woodbury et al. [55] reported the unexpected capacity of adult human and rat MSCs derived from bone marrow to turn into neuron-like cells after various types of treatments. The cells expressed neural-specific proteins, including NSE (neuron-specific enolase), NF-M (neurofilament N), and nestin, but the cells did not express GFAP (astrocyte marker, glial fibrillary acidic protein). Therefore, there is a notion that cultured MSCs are relatively homogeneous and could contain subgroups of cells with distinct properties that are composed of cells at different stages of commitment, self-renewal and have the capacity to express different gene products [34] . Additionally, the observation of a neural-like morphology considered to be a bona fide neuron continues to be the focus of intense debate [29] .
In this study, we showed a significant improvement in β-tubulin III neural protein expression using visible lowintensity laser light irradiation (650 nm) alone or in association with e nanotechnology to design a drug delivery system for NF. This concept has been used worldwide with a positive response resulting from most attempts. The nanoparticles designed for NF was able to influence specific cytoskeleton neural protein expression in bone marrow 1 3 hMSCs compared to the FF drug. We believe that these results are very promising and that this approach could be used for up-regulation of neural proteins and possibly other proteins related to hMSCs.
Materials and Methods

Ethics Statement
This study was approved by the Human Research Ethics Committee of the Faculty of Philosophy, Science and Letters, Department of Chemistry -University of São Paulo, Ribeirão Preto, and it was conducted according to the requirements of the Hospital Amaral de Carvalho (HAC, Jau, SP) and following the recommendations in the Declaration of Helsinki. Written informed consent was obtained from each donor. Human bone marrow samples were harvested from the iliac crest in allogeneic transplants from healthy adult subjects (permit number, 493.260).
Isolation of hMSC
Mononuclear cells (MNCs) were isolated from bone marrow. Briefly, the cells were separated using 1077 g/mL of Ficoll-HyPaque™ Plus (Histopaque-10177, GE HealthCare Bio-Sciences, Uppsala, Sweden). The density gradient was used in the isolation procedure to eliminate unwanted cell types that were present in the bone marrow aspirate. A small percentage (estimated approximately 0.01%) of cells were isolated, attached and grown as fibroblast-like cells. Haematopoietic stem-cells (HSC) and non-adherent cells were removed when the medium was changed [41] . At this point, the cells were seeded in DMEM supplemented with 10% FCS (HyClone, Logan, UT, USA), 100 IU/mL of penicillin and 100 µg/mL of streptomycin (both Sigma, St Louis, MO, USA). After 2 weeks, the cells were detached with trypsin solution (0.025%) and EDTA (0.5 mM) (ScienCell, Carlsbad, CA, EUA) and were grown to approximately 85% confluence in a 37 °C humidified incubator with 5% CO 2 . Bone marrow-derived-hMSC from 1 to 3 independent donors were used from the 3rd to 5th passages and analysed.
Immunophenotyping
Aliquots of 1.0 × 10 5 cells were harvested from the 3rd passage and centrifuged at 400xg at room temperature for 10 min. Afterwards, the cells were labelled with anti-human primary monoclonal antibodies conjugated with fluorochromes, including fluorescein isothiocyanate (FITC) or phycoerythrin (PE) according to the protocol described by the manufacturer (Becton Dickinson, San Jose, CA, USA). The antibodies that were used were CD13-PE, CD14-PE, CD29-PE, CD31-FITC, CD34-PE, CD44-PE, CD45-FITC, CD49e-PE, CD51/61-FITC, CD54-PE, CD73-PE, CD90-PE, CD105-PE, CD146-PE, HLA (class-I)-PE and HLA-DR (class-II)-FITC.
IgG1-FITC, IgG2a-PE, IgG1-PerCP (peridinin chlorophyll protein) and IgG-APC (allophycocyanin) (Becton Dickinson, San Jose, CA, USA) served as negative controls. Cells (10,000 events) were analysed in a FACScalibur flow cytometer (Becton-Dickinson, Mountain View, CA, USA). Data were acquired and analysed using the CELL Quest software (Becton-Dickinson, Mountain View, CA, USA).
Nano-Forskolin Preparation
Nanoemulsions (NE) were obtained with the spontaneous emulsification process described by Primo et al. (2008) . Briefly, the organic phase was prepared containing phospholipids Epikuron® 170 (7.5%) (Lucas Meyer, France/Aldrich, USA) in pure acetone at 55 °C. Forskolin (Sigma-Aldrich, USA) was previously dissolved in mineral oil Miglyol 812N (Stallergenes S.A., France) at a concentration of 20 µM, and it was added directly to the organic solution. Subsequently, this organic solution was slowly injected into an aqueous phase containing the biopolymer Pluronic F68 (Sigma-Aldrich, St Louis, MO, USA) (7.5%) and mixed with magnetic stirring (300 rpm for 20 min) at 55 °C. Water was supplied with the E-Pure Barnstead D 3750 purification system. Final emulsification was obtained through rota-evaporation under reduced pressure at 65 °C and pressure < 1 atm. Nanoemulsions without the incorporation of forskolin were also prepared under the same conditions. All formulations were stored at 4 °C in the dark for 120 days.
Free-Forskolin Treatment
The cells were seeded in 6-well plates at a density of 1 × 10 6 cells/well in DMEM supplemented with 1% FCS (foetal calf serum), 100 IU/mL penicillin and 100 µg/mL of streptomycin in fresh culture medium containing 100 ng/mL bFGF (PeproTech, Rocky Hill, NJ) for 7 days. Afterwards, hMSC were incubated in culture medium and treated in the absence (MSCs control) or in the presence of 10 µM free-forskolin (Sigma Chemical Co.) for up to 7 days. The cell cultures were incubated at 37 °C with 5% CO 2 ( Fig. 1 ).
Nano-Forskolin Treatment
The cells were seeded in 24-well plates at a density of 1 × 10 6 cells/well in DMEM supplemented with 1% FCS, 100 IU/mL penicillin and 100 µg/mL of streptomycin in fresh culture medium containing 100 ng/mL bFGF for 7 days. Afterwards, hMSC were incubated in culture medium and treated in the absence (control MSCs) or in
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the presence of NF with the following concentrations: 0.5; 1.0; 5.0; 7.5 and 10 µM for 3 h. After incubation, the cells were washed three times, and the volume was replaced with culture medium in each well. The cell cultures were incubated at 37 °C with 5% CO 2 .
Photobiological Assays
To investigate the potential effects of visible light on neural protein expression using light photobiomodulation with low-intensity laser light protocol alone or in association with FF and Nano-Forskolin, the hMSCs where treated as described above. For the photobiomodulation studies, fresh medium without phenol red was added, and the cells were irradiated with a diode Eagle laser (Quantum Tech, São Carlos, SP, Brazil). All the laser irradiation procedures were performed under the following conditions: a wavelength of 650 nm, average power set to 50 mW, and light irradiance at 5.5 mW cm 2 . Cells were exposed to light doses of 10, 20, and 40 mJ/cm 2 . The parameters used in this study are shown in Table 1 . After irradiation, the cells were maintained in medium culture at 37 °C in a humidified atmosphere of 5% CO 2 overnight. All the assays were carried out in triplicate.
Cellular Viability
Flow Cytometry
To assess viability, control and FF-treated hMSC (1 × 10 5 cells) were harvested after the last incubation and stained with 50 μg/mL propidium iodide (50 mg/mL) (DNA intercalating dye) (Sigma-Aldrich, St. Louis, MO, EUA). Cells (10.000 events) were then analysed in a FACSCalibur flow cytometer using an argon ion laser with an incident beam set at 488 nm. Red fluorescence was analysed through a long pass filter set a 670 nm. Data were acquired and analysed using Cell Quest software.
MTT Assay
The hMSCs were seeded at a density of 2 × 10 3 cells/well in a 96-well microplate and treated with NF at 0.5, 1.0, 2.5, 5.0, 7.5 and 10 μM for 3 h in culture medium containing 1% FCS. Afterwards, the cells were washed three times with PBS and maintained in culture medium at 37 °C in a humidified incubator with 5% CO 2 overnight. The control group was cultured in the absence of the drug. The cell viability was measured using MTT reagent (tetrazolium
The MTT solution (5.0 mg/mL) was added to the MSCs at a proportion of 30 μg/mL to 170 μg/mL of culture medium (without FCS and phenol red) and then incubated in 5% CO 2 at 37 °C for 4 h. After the final incubation, the medium was removed, and crystals formed due to the association between the mitochondrial dehydrogenases and the MTT reagent, which were dissolved with 200 μg/mL of 2-propanol. This colourimetric assay measures the reduction of the reagent with a compound named formazan by the action of mitochondrial dehydrogenases. The reduced formazan crystals were quantified using a spectrophotometer. The absorbance at 560 and 690 nm of each well was measured directly with a multiplate reader from Safire II (Tecan Trading AG, Mannedorf, Switzerland) to measure mitochondrial dehydrogenases and MTT, respectively, according to the mitochondrial activity of viable cells.
Morphological Analysis
Phase-Contrast Microscopy
The cells were observed daily using an inverted microscope (Olympus 1 × 71, Tokyo, Japan) and phase-contrast microscopy for morphological analysis. Photographic Fig. 1 Diagrams illustrating the neural induction protocols using 100 ng/mL bFGF in DMEM containing a low concentration (1%) of FCS for 7 days, followed by free-forskolin treatment for 10 µM up to 7 days (a) and nanoforskolin for 3 h (b) up to 7 days. On the 8th day, the cells were subjected to low-level laser irradiation Stem Cell Reviews and Reports (2018) 14:585 598 -588 documentation was performed with a digital camera (Olympus UTVO 5XC-3, Tokyo, Japan).
Immunofluorescence Assay
Immunofluorescence was performed to detect neural markers. Control and treated hMSCs were seeded at a density of 1 × 10 4 cells/well on glass coverslips (GoldLab, Ribeirão Preto, SP, Brazil) in 24 well-microplates (CoStar, Corning, NY, USA), as described previously. The cells were fixed in 2% paraformaldehyde (Sigma, St Louis, MO, USA), for 10 min at room temperature. Both types of cells were washed three times with PBS and blocked with 0.1 M glycine (Pharmacia Biotech, AB, USA) for 30 min. Then, the cells were permeabilized with 0.3% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) for 10 min at room temperature and blocked for 1 h with 1% bovine serum albumin (BSA) and 2% goat serum in PBS.
Samples were incubated with the primary antibodies anti-Nestin (Cat#MAB5326, Millipore), and anti-β tubulin III (Cat#MAB1637, Millipore) separately at room temperature for 1 h. The secondary antibody was the Alexa Fluor 488 mouse antibody (Cat# A-21,202, Invitrogen, Carlsbad, CA, USA). Nuclei were stained with DAPI (4´,6-diamidino-2-phenylindole) (Vysis, Des Plaines, IL, USA). Sections of human nerve were used as positive and negative controls. The negative control was incubated in the absence of primary antibodies.
Cells were visualized using a confocal laser scanning microscope (CLSM) (LSM 710; Carl Zeiss, OberKochen, Germany) with a 63 × objective lens in immersion oil and an aperture of 1.4. An argon laser at 488 nm was used to excite secondary antibodies and emission was measured at 525 nm. Visualization of the light scattering for each excitation wavelength was recorded in multitracking mode using separate detection channels. Image analysis was carried out using the ZEN 2008 software (Carl Zeiss). Control and test images were captured using identical settings.
Quantitative Analysis
Controls and treated hMSCs were seeded at a density of 1 × 10 3 cells/well in the 96-well microplates without coverslips (CoStar, Corning, NY, USA), as described above.
To perform quantitative analysis, the fluorescence intensity of the β-tubulin III was detected using High Content Imaging (INCell analyser 2200 system) and INCell investigator v.1.6.1 software (GE Healthcare Life Sciences, Upsala, Sweden). The system can remove cellular debris and background from the analyses.
Western Blot Analysis
Protein samples were extracted using RIPA buffer containing protease and a phosphatase inhibitor cocktail (Sigma, St. Louis, USA), centrifuged at 20.000 rpm for 20 min at 4 °C, and the protein concentration in the supernatant was determined with the Bradford method (Bio-Rad Lab, California, USA). A similar amount of total cell lysate was fractionated through 12% SDS-PAGE and transferred to nitrocellulose membranes (Bio-Rad Lab, California, USA). The proteins transferred to the membrane were visualized by a 0.3% Ponceau solution stain for 5 min. Later, the blots were blocked in TBS-T (50 mM Tris, pH 8.0, 150 mM NaCl, containing 0.1% Tween 20) and 5% non-fat dry milk. Immunodetection was performed with a monoclonal mouse antibody against β-tubulin III (similar to TUJ1) and nestin (Cat#MAB5326, clone 10C2; Millipore). The first antibody recognizes the protein C-terminal region (clone TU-20, Millipore, Temecula, CA.) (Cat#MAB1637, Millipore). The membrane was incubated with an anti-IgG mouse secondary antibody conjugated with peroxidase (KPL Laboratories, Inc, USA). The bands of the immunoreactive polypeptides were detected by chemiluminescence using an ECL plus kit (Amersham Biosciences Co., Piscataway, NJ) according to the manufacturer's instructions (BioRad, Lab, California, USA). A molecular weight marker was used as a molecular mass standard. Purified swine brain tubulin was used as a positive control. Densitometric analyses of β-tubulin III bands of different groups were performed using ImageJ software developed by the National Institutes of Health (NIH).
Statistical Analysis
Experimental and control groups were conducted using oneway analysis of variance (ANOVA) followed by Tukey's post hoc test conducted with SAS® 9.2 software, Inc. (San Diego, CA, USA). The results are presented as the means (± S.D.). The level of significance was 5%. In Fig. 7 , the box plot is one of the most common standard ways to evaluate and compare data distributions. The box indicates 50% of the data between the 25th and 75th percentiles, i.e., the lower and upper quartiles, and it draws focus to the centre of the distribution. The median, is represented by the line inside the box, and the mean is indicated by a spot. The vertical lines from the box represent the minimum and maximum values. The outliers are elements that do not comply with a given pattern in a set.
Results
Immunophenotyping of hMSCs
Analysis of the surface markers using flow cytometry showed that the cells exhibited hMSCs-specific markers,
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including CD13, CD29, CD49e, CD90, CD44, CD54, CD73, CD105, CD166 and HLA (class-I) ( Table 2 ). The haematopoietic stem cells markers CD14, CD34, CD45, CD31, CD51/61, CD106 and HLA-DR (class-II) were not expressed or had a small proportion of expression (Table 3) .
Dose-Response Effects of Low-Intensity Laser Irradiation on Cellular Viability in hMSCs
Flow cytometry data showed that 89.3% (± 1.7) of control hMSCs (0 mJ/cm 2 ) were viable cells (Fig. 2a) . After lowintensity laser irradiation with 10 and 40 mJ/cm 2 doses, there was a decrease in viable cells to 79.3% (± 2.4) and 78.8% (± 0.6), respectively. The hMSCs subjected to the 20 mJ/cm 2 dose maintained viable cells at 88.5% (± 0.9). The 20 mJ/cm 2 dose was considered the most efficient due to its satisfactory threshold for cell viability.
After treatment with 10 µM FF, a reduction in the proportion of viable cells, 78.7% (± 3.7), was observed (Fig. 2b) . After 10 µM FF treatment plus low-intensity laser irradiation at the doses 10, 20, and 40 mJ/cm 2 , there was not a statistically significant reduction (P < 0.05) in the percentage of viable cells (Fig. 2b) . Taken together, these results showed that a dose of20 mJ/cm 2 is the most likely dose to be used in studies of the photobiostimulation process. In the Photobiomodulation process, investigators should always look for a better balance between the dose of light that is applied, the quantity of photons produced and absorbed in a biological effect, and take steps to avoid big changes in cell viability that could trigger other cellular responses.
Dose-Response Effects of NF on the Cellular Viability of hMSCs and Morphological Evaluation
The MTT assay was performed to evaluate the cell viability of NF at various concentrations. Control hMSCs showed 100% (± 0.05) viable cells (Fig. 3a) . After treatment at concentrations of 0.5 and 1.0 µM, it was possible to maintain the number of viable cells at approximately 88.7% (± 10.7) and 88.8% (± 11.4), respectively (Fig. 3a) , which indicated that a dose of up to 1.0 µM is satisfactory for the conservation of cellular viability. Then, all experiments using NF were conducted with this dose (1.0 µM). hMSCs treated with 2.5 µM NF showed a reduction in the proportion of viable cells to 48 .4% (± 6.0) (P < 0.05) (Fig. 3a) .
Phase-contrast microscopy of hMSCs treated with 1 µM NF showed an increase in the proportion of adherent cells (Fig. 3b) , but we did not observe neuron-like alterations. In contrast, the 10 µM NF induced a decrease in the percentage of adherent cells and acquired a phenotype resembling neurons, which suggested that a subset of hMSCs can alter their phenotype in response to the stimuli, although the proportion of these cells was low (Fig. 3c) .
As shown in Fig. 4 , the incubation of hMSCs with 10 µM FF exhibited neural-like morphology after 3 days (Fig. 4b ) and 4 days (Fig. 4c, d) , and the cells were morphologically distinct from the undifferentiated hMSCs (Fig. 4a) . We noticed that the appearance of some cells reverted to a fibroblast-like morphology at the end of the treatment, i.e., up to 7 days post-drug treatment (data not shown). After 8 days, hMSCs were subjected only to low-intensity irradiation (20 mJ/cm 2 ) (Fig. 4e ) and 10 µM FF treatment plus 20 mJ/ cm 2 irradiation did not appear to have an altered neuron-like morphology (Fig. 4f) .
Detection of a β-tubulin III Neural Marker by Immunofluorescence
After 8 days, the β-tubulin III expression was observed in control MSCs (Fig. 5a ) and in cells treated only with lowlevel laser irradiation (20 mJ/cm 2 ) (Fig. 5b) , treated with 10 µM FF (Fig. 5c ), or treated with 10 µM FF plus 20 mJ/ cm 2 laser irradiation (Fig. 5d) . The β-tubulin III expression was also observed after 8 days in control MSCs (Fig. 6a ) and in cells treated only with low-level laser irradiation (20 mJ/cm 2 ) (Fig. 6b) or (Fig. 6c ). The treatment with 1.0 µM NF plus 20 mJ/cm 2 laser irradiation seems to be more effective for inducing phenotypic changes because the cells had a neuron-like morphology with a well-defined body cell and longer processes (Fig. 6d) compared to other groups. β-tubulin III was detected in human nerve sections that were used as positive and negative controls (Fig. 6e, f) . No nestin expression was detected in all eight groups. The cells were analysed using scanning laser confocal microscopy.
Quantitative Analysis of Fluorescence Intensity for β-tubulin III Expression by High Content Imaging
Data from the box plots graphs showed that after exposure using a low-power laser, there was a tendency to increase the β-tubulin III expression in all groups. Notably, the photobiostimulation process was greater in the irradiated nanoforskolin group [INF] (Fig. 7) .
Western Blot
A Western blot confirmed the expression of β-tubulin III (55 kDa) (Fig. 8) , which was increased in non-irradiated and irradiated control MSCs corresponding to the FF and NF treatments. However, we observed that there was downregulation of β-tubulin III in the presence of the free-form drug, which suggested there was a transient effect on the As expected, after NF treatment, there was an improvement in the drug delivery system. An increase in the neural protein was observed after densitometric analysis of the bands. INF was the most effective (105%) compared to IFF (53%), and in non-irradiated cells, the NNF (102%) was most effective compared to FF (68.2%). Interestingly, the levels of protein were 68.2% for FF versus 53% for FFI (Fig. 8) . In contrast, the nanodrug was able to maintain levels of protein similar to the controls (100% and 99%). It is noteworthy that the dose used for NF was ten times smaller (1.0 µM) compared to FF (10 µM) and had a shorter incubation time, i.e., 3 h versus 7 days for FF. Although, the final incubation time in culture was the same for all groups.
Discussion
In the present study, we were interested in inducing up-regulation of neural proteins to eventually generate cells with a neuron-like lineage. To accomplish this goal, low-level laser irradiation and drug delivery systems were used. The data showed that the flow-cytometry analyses were consistent with previous studies [41] , which confirmed that the cells used in this study are MSCs. Our data showed a trend in the improvement of β-tubulin III marker expression, which is a member of the microtubule family, after low-level laser irradiation in all groups. Neurobiology researchers found that the phosphorylated form of this protein is neuron-specific, and it is detected during early brain development and is down-regulated in adulthood [20] . Tubulin consists of an α/β heterodimer, and each of these peptides exists in different isoforms [28] .
Importantly, in this study, the FF responsiveness to β-tubulin III down-regulation could be related to the increase in cAMP levels, which could have occurred in a fast, potent, but reversible pathway [49] . In fact, Rooney et al. [46] showed that in rat bone marrow MSCs, FF induced a sixfold increase in β-tubulin III expression after 6 h of exposure time, which was followed by alterations in morphology. However, this effect was transient because the cells reverted to their normal morphology in 24 h.
Despite this evidence, we believe that long-term culture is fundamental to our understanding of β-tubulin III downregulation after FF treatment. The differences observed in the mechanism of action for the drug may be related both to the origin tissue and to species, i.e., intrinsic genetic differences between mice and human beings.
Jang et al. [18] used a long-term culture protocol for neural enrichment for 14 days (bFGF for 7 days and FF for up to 7 days) using adipose tissue-derived hMSCs. The immunofluorescence results showed expression of β-tubulin III, GFAP and nestin, among other neural markers. Therefore, the authors demonstrated the efficiency of the protocol, which resulted in functional neurons according to patch clamp tests [18] . This outcome could be related to tissue specificity. In our study, we still do not know if the cells exhibit functional properties, so electrophysiological evaluation by patch clamp technique might be required in a future study.
Notably, our study showed that low-level laser irradiation exposure for control hMSCs (corresponding to the nanodrug group) has a photobiostimulatory effect, which indicates that irradiated cells present potential for β-tubulin III up-regulation. These results, at least in part, agree with the results of Yu et al. [57] , who reported enhanced release of bFGF in cultured 3T3 fibroblasts (mouse embryo) after irradiation with a 660-nm laser at a dose of 2.16 J/cm 2 . The laser photobiostimulation effect appears to be dependent on the wavelength and on the energy level delivered to the cells. Studies indicated that this effect occurs between 0.05 and 10 J/cm 2 and has an effect on DNA synthesis, protein (collagen) and cell proliferation [57] .
Therefore, we could speculate that in our system, i.e., laser irradiation exposure on hMSCs with 660 nm and at a showed cells resembling neuronal morphology with neuron-like cell bodies and longer processes compared to other groups (d). Human nerve sections were used as positive controls and as negative controls (suppressing the primary antibody) (e) and (f). Nuclei were stained with DAPI (blue). Cells were analysed using scanning laser confocal microscopy 1 3 dose of 20 mJ/cm 2 could induce a possible release of bFGF in cell culture and could increase the effect on β-tubulin III synergistically compared to non-irradiated control cells (i.e., the free-form drug group, FF). This evidence would also explain the minor effect observed compared to the NF group subjected to laser irradiation (FNI), in which bFGF release could compete with the drug compared to control cells (CNI).
Additionally, Tondreau et al. reported that naive MSCs express neuronal and glial proteins before responding to differentiation signals, and they have increased expression under appropriate stimuli.
We also found the glial protein GFAP in hMSCs, which developed structures similar to neurite outgrowth after NF treatment, which suggested a neural phenotype was enriched (data not shown).
Furthermore, the establishment of culture systems that do not depend on the FCS addition is very desirable due to reduction of the risk of contamination by xenogeneic agents and using culture cells in human cell therapy.
In this work, we argue that the use of irradiation along with nanotechnology (NF) could be a better approach for neural protein induction due to the maintenance of β-tubulin III levels compared to NFFC and FF, which showed signs of down-regulation. More importantly, NF was used at a lower concentration (1 µM) versus (10 µM FF) and had a shorter incubation time (3 h versus 7 days for FF) although the overall time in culture was the same for all groups. Immunofluorescence results and Western blot results indicate that increased β-tubulin III expression was not merely a consequence of an increase in antigenic levels per relative unit. This concept was previously discussed by Kingham et al. [53] in their studies on glial proteins.
In our investigation, nestin was not observed. Nestin, which is an intermediate filament protein, was first reported in neuroepithelial neuronal precursor stem cells, and its expression decreases with neuronal maturation [25] . It is known that nestin expression is also detected in different cell types in the nervous system as well as in other tissues, such as skeletal muscle [6, 25] and heart tissue [6] .
Woodbury et al. [55] demonstrated high levels of nestin expression at 5 h and 1-day post-treatment, but there was a decrease after 6 days in a subset of neuron-like derived rat MSCs, which indicated there was cellular maturation during this time.
There are several studies showing in vitro enrichment of MSCs towards neuronal and/or glial fates using different Fig. 8 Expression of the β-tubulin III protein was detected by Western Blot in hMSCs. Densitometric analysis of the bands for β-III tubulin revelead that the levels of protein were 100% in NFFC versus 68.2% in IFFC (10 mM) (both in the absence of low-intensity irradiation). After the exposure in to low-level irradiation, percentage was maintained in about 99% (IFFC) versus 53% after treatment of IFFC (10 mM). In the nano-drug treatment, levels of protein were 100% (NNFC) versus 102% of NF (1 mM culture conditions. The protocols typically involve induction with chemical agents. For instance, supplemented media with cytokine cocktails: EGF (epidermal growth factor), BDNF (brain-derived neurotrophic factor), and bFGF concomitant or not with other drugs, such as alltrans-retinoic acid [47] , β-mercaptoethanol (BME) and butylated hydroxyanisole [55] , BME followed by retinoic acid and forskolin [16] , forskolin [8] or bFGF plus forskolin [18, 29] .
Additionally, Arthur et al. [4] used retinoic acid for neural induction and reported that human adult dental pulp stem cells (DPSCs) acquired a neuron-like morphology (bipolar and stellate form) and expressed the neural markers nestin and α-tubulin III (at both the mRNA and protein levels). Furthermore, the cells produced a sodium current that was enhanced after stimulation, which indicated there were functional properties.
Currently, it is known that pluripotent stem cells treated with retinoic acid (a metabolic compound derived from vitamin A) undergo neurogenesis in vitro, which leads to increased aneuploidy and micronuclei generation. This fact should be accurately considered before employing in vitro neural derived-pluripotent stem cells in cellular therapy [48] .
In summary, culture-expanded adult hMSCs under lowlevel laser irradiation conditions demonstrated photobiostimulation effects on β-tubulin III neuronal protein. To the best of our knowledge, this is the first report considering the combination of irradiation and nanotechnology for improving protein expression related to neuronal-like phenotypes in vitro. We believe that these methods could be used for the enrichment of proteins related to hMSCs. Furthermore, basic science studies provide a better understanding of drug delivery systems that will be crucial to support cell-therapy protocols in the future.
